Email Updates

Search form

You are here

30 NOVEMBER 2018 VOLUME 19 ISSUE 48

Media Coverage

  • The Centre for the AIDS Programme of Research in SA (CAPRISA) has done trials on animals using a matchstick-sized implant containing Tenofovir Alafenamide (TAF), a more potent version of the ARV drug Tenofovir.

    November 30, 2018
    IOL
  • Across the HIV care continuum, health workers play essential roles in educating, treating, and supporting patients as they seek to prevent or address HIV infection. We know that community health workers in African countries play key roles in service delivery for both prevention and treatment, yet community health worker programs for HIV lack adequate, long-term resources.

    November 30, 2018
    General
    STAT
  • As another World Aids Day pulls into view, scientists are beginning to ask if the biggest breakthrough – an out-and-out cure for the tens of millions who have contracted the virus – could be in sight. The excitement lies in research that is having some success in drawing the virus out of a latent stage (in which it can lie undetected for long periods) so that it could be destroyed.

    November 30, 2018
    The Guardian
  • Ahead of World AIDS Day, Uganda is recruiting women to participate in a trial of an injectable antiretroviral drug to replace Truvada, a daily pill that has low adherence by users. The trial will assess if the new drug - Cabotegravir - can further reduce the risk of acquiring HIV.

    November 30, 2018
    VOA
  • Popularly known as Supercharger, a famous radio personality of yesteryear, Moses first knew he had HIV in 1993 but lived in denial for five years until his family decided to take him to their burial ground in Ntenjeru, Kayunga District.

    November 29, 2018
    Daily Monitor
  • Public Health England (PHE) recorded a drastic fall in new diagnoses of HIV in the UK, with just 4,363 new cases diagnosed in 2017. This represents a 17 percent year-on-year decrease.

    November 29, 2018
    General
    PinkNews
  • Men are far more likely to die from an HIV-related illness than women, although women are becoming infected with HIV at a much faster rate.

    November 29, 2018
    General
    Daily Nation
  • President Donald Trump will soon sign legislation to extend a 15-year-old HIV/AIDS program that has helped millions, primarily in Africa. HIV/AIDS advocates welcomed the news and immediately called on Trump to drop efforts to cut federal funding for the life-saving program.

    November 29, 2018
    General
    Chicago Sun Times
  • Researchers have apparently solved a major technical difficulty that has long impeded efforts to develop a highly effective HIV vaccine, finding that their strategy led to a powerful antibody response in animals.

    November 29, 2018
    POZ
  • In a world hemmed in by patriarchy and poverty, cash transfers could be the missing link in SA’s HIV prevention programmes.

    November 29, 2018
    General
    Bhekisisa
  • On 27 November 2018 the FDA approved a generic combination tablet of tenofovir disoproxil fumarate plus lamivudine (TDF/3TC) tablets for use in the U.S.

    November 29, 2018
    The BodyPro
  • Stigma around homosexuality and drug use means Russia and some former Soviet Union countries risk developing out-of-control HIV epidemics, experts have said, after data showed a record number of new cases last year.

    November 28, 2018
    General
    The Guardian
  • Southwest China's Yunnan Province logged 9,413 new HIV/AIDS cases from January to October this year, down 2.6 percent year on year, a downward trend for five consecutive years, local authorities said Tuesday.

    November 28, 2018
    General
    Xinhua
  • Before the news broke Sunday that Chinese researcher He Jiankui had used the genome-editing technology CRISPR to create genetically altered twins, he was little known in scientific circles. But the controversial experiment to make humans potentially resistant to HIV also thrust another player into the limelight: CCR5, an immune system molecule that He attempted to cripple. Here’s the scientific logic behind that choice—and the concerns.

    November 28, 2018
    General
    Science
  • HIV induces antibody responses in infected individuals, but only a few of these individuals manage to produce antibodies that are capable of viral neutralization—and even fewer produce antibodies that can neutralize different strains of HIV.

    November 28, 2018
    Antibody Related Research, HIV Vaccine
    Nature
  • Good Participatory Practice (GPP) has become a central part of biomedical HIV prevention research over the past 10 years. Developed in response to global controversies that disrupted the first trials seeking to test whether antiretroviral drugs could prevent the sexual transmission of HIV, GPP provides a framework for researchers working amid historically-based concerns about exploitation and within the pervasive social, economic and political inequalities that travel with the HIV pandemic.

    November 27, 2018
    General
    Research for Evidence
  • Zimbabwe is recording 250 new HIV infections weekly said to be fuelled mostly by adolescent girls, a development which may hinder progress towards ending AIDS by 2030.

    November 27, 2018
    General
    Nehanda Radio
  • More than 130,000 people were newly diagnosed with HIV last year in Eastern Europe, the highest rate ever for the region, while the number of new cases in Western Europe declined, global public health experts said on Wednesday.

    November 27, 2018
    General
    Reuters
  • We could be just months away from knowing whether Depo-Provera use is linked to a higher risk of HIV infection in women.

    November 23, 2018
    Bhekisisa

Published Research

Announcements